Despite the complexity of RHAMM’s functions, its limited expression in normal physiological conditions, correlation with poor cancer outcomes, and involvement in processes like inflammation and fibrosis [47,48], which can aggravate cancer progression, make it a compelling candidate for therapeutic targeting. Here, HMMR is linked to cancer.